Cases & Deals

Genomatica enters sponsored research agreement relating to biofuels, acquires technology from REGI

Clients Genomatica, Inc.

Jones Day represented Genomatica, Inc. in entering a sponsored research agreement for the development of advanced biofuels and acted as special IP counsel to Genomatica in its simultaneous acquisition of the assets of the life sciences division of Renewable Energy Group, Inc. ("REGI"). The technology assets acquired from REGI are Genomatica's third technology platform and will be used by Genomatica to make long chain chemicals and continue biofuels research and development started by REGI before the acquisition.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.